Indian J Pharm Close
 

Figure 2: Relapse free survival (a), event free survival (b). Median OS for all patients is 128 months. Median EFS is 61 months and median RFS is 61 months. In this cohort, the 2-year Kaplan-Meier estimates of OS, DFS and EFS were 75.13% ± 8.51%, 83.08% ± 1.1%, and 62.15% ± 1.08%, respectively

Figure 2: Relapse free survival (a), event free survival (b). Median OS for all patients is 128 months. Median EFS is 61 months and median RFS is 61 months. In this cohort, the 2-year Kaplan-Meier estimates of OS, DFS and EFS were 75.13% ± 8.51%, 83.08% ± 1.1%, and 62.15% ± 1.08%, respectively